I-INR ivame ukusetshenziselwa ukukala umphumela wemithi yokwelapha ukugoqa igazi ngomlomo esifweni se-thromboembolic. I-INR ende ibonakala kuma-anticoagulant omlomo, i-DIC, ukuntuleka kwe-vitamin K, i-hyperfibrinolysis njalo njalo. I-INR emfushane ivame ukubonakala ezimweni ezigoqa igazi kakhulu kanye nezinkinga ze-thrombotic. I-INR, eyaziwa nangokuthi i-International Normalized Ratio, ingenye yezinto zokuhlola umsebenzi wokugoqa igazi. I-INR isekelwe ku-reagent ye-PT yokulinganisa i-International Sensitivity Index futhi ibale umphumela ngokusebenzisa amafomula ahlobene. Uma i-INR iphezulu kakhulu, kunengozi yokopha okungalawulwa. I-INR ingaqapha futhi isebenzise ngempumelelo umphumela wemithi yokwelapha ukugoqa igazi. Ngokuvamile, kusetshenziswa umuthi wokwelapha ukugoqa igazi i-warfarin, futhi i-INR idinga ukubhekwa ngaso sonke isikhathi. Kufanele wazi ukuthi uma kusetshenziswa i-warfarin, i-INR kumele ihlolwe njalo. Iziguli ezine-venous thrombosis kumele zithathe i-warfarin ngomlomo, futhi inani le-INR kufanele ligcinwe ku-2.0-2.5. Ezigulini ezine-atrial fibrillation, inani le-inr le-warfarin yomlomo ngokuvamile ligcinwa phakathi kuka-2.0-3.0. Amanani e-INR angaphezu kuka-4.0 angabangela ukopha okungalawuleki, kuyilapho amanani e-INR angaphansi kuka-2.0 enganikeli ukuvimbela ukujiya kwegazi okusebenzayo.

Isiphakamiso: qhubeka uye esibhedlela esivamile ukuze uyohlolwa, futhi ulalele ilungiselelo likadokotela ochwepheshe.